Friday, 3 February 2017

New cancer drug ‘refused’ by NICE

Palbociclib not ‘cost effective’

Related items from OnMedica

Cancer drug access in England is a ‘debacle’
Study shows huge global variation in cancer drug costs
The medicine price debate
UK patients losing out in access to cancer drugs
NHS cancer patients still denied treatments available in other countries
via OnMedica News Read More Here..

No comments:

Post a Comment